Company
GINPACT was co-founded in Hong Kong in August 2024 by world-class biologists and technology investors. The company is dedicated to modernizing, democratizing and globalizing precious traditional herbs, such as ginseng and notoginseng, through cutting-edge biotechnology. The flagship product, Rare GINPACT Essence, stems from over two decades of scientific research into Panax species and fermentation technology. Utilizing proprietary and original technology, we convert cultivated ginseng and notoginseng into rare, natural tonic essence that mirror the potency of wild mountain ginseng.
In collaboration with top universities in Hong Kong, our research has substantiated that GINPACT supports DNA repair, mitochondrial function restoration, and NAD+ levels elevation, all while maintaining an exceptional safety profile. By validating the traditional efficacy of wild mountain ginseng—"nourishing the five internal organs and calming the spirit"—with modern science, we deliver a product that is not only potent but also free from pesticide residues and heavy metals, ensuring the highest standards of food safety.
